PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

PAR & Chrons Disease, page-12

  1. 1,045 Posts.
    lightbulb Created with Sketch. 95
    Nothing wrong with a crazy dream and a dollop O passion Mozzie, your informative posts are appreciated and definitely have noted the considerable work goes into many.
    On another matter unrelated to PAR and not of good etiquette here however I noticed CMP another health tech company that I hold had an 8% increase in price on good volume today. It has always had good potential and have a feeling that all the planets are lining up at the moment. I also have a feeling I am going to find out how some of that alignment is going on Monday so hey it may be interesting for some and a possible dabble. Thinking the possible thrust is due to the development of high resolution brain scan technology called a MEG which will raise $4m a pop and a market in the $B’s. CMP has 20+ years of history and many products I would consider world class.
    Anyway I do hope I haven’t upset anyone mentioning this company as simply thought it may be of interest to some.
    Here is a presentation to add:
    https://www.compumedics.com.au/wp-content/uploads/2019/03/Compumedics-CMP-Corporate-Presentation-April-2019.pdf

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.